<i>SLC6A8</i> is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yongfei,Fan

第一单位： Department of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.

作者： Yongfei,Fan ^[1] ; Yong,Zhou ^[1] ; Ming,Lou ^[1] ; Zhaojia,Gao ^[1] ; Xinwei,Li ^[2] ; Kai,Yuan ^[3]

作者单位： Department of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China. ^[1] Heart and Lung Disease Laboratory, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China. ^[2] Department of Gastroenterology, Affiliated Cancer Hospital of Bengbu Medical College, Bengbu, China. ^[3]

关键词 SLC6A8 biomarker immunomodulator lung adenocarcinoma prognosis

DOI 10.3389/fgene.2022.845373

PMID 35692837

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in genetics

2022年13卷

845373页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

<i>SLC6A8</i> is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

<i>SLC6A8</i> is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma.

Frontiers in genetics

相似文献

Frontiers in genetics

相关期刊

检索历史清除